Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Neoplasm With Metastasis”

1,102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,102 results

Not applicableStudy completedNCT01227213
What this trial is testing

The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
HypertensionRenal FunctionInsulin Sensitivity+1 more
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT03136627
What this trial is testing

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 28
Early research (Phase 1)Study completedNCT00112476
What this trial is testing

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Early research (Phase 1)Study completedNCT03063762
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Post-approval studies (Phase 4)Looking for participantsNCT06903312
What this trial is testing

Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Who this might be right for
Renal Cell CancerKidney NeoplasmImmunotherapy+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 409
Testing effectiveness (Phase 2)Ended earlyNCT01391130
What this trial is testing

LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Eli Lilly and Company 110
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Not applicableWithdrawnNCT01977586
What this trial is testing

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Imperial College Healthcare NHS Trust
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Ended earlyNCT00496756
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska 14
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Large-scale testing (Phase 3)Study completedNCT00005995
What this trial is testing

AE-941 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
AEterna Zentaris
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Next Page